JAK Inhibitor & IL17: Improving Outcomes and Exceeding Expectations

Overview

We are pleased to invite you to the webinar titled ‘JAK Inhibitor & IL17: Improving Outcomes and Exceeding Expectations'. Where our speakers will be sharing their experience through clinical cases of RA and PsA. As well as, the latest long-term efficacy and safety related data.

This Activity for

• Resident / Fellow
• Physician
• Clinical Pharmacy

What I will learn?

- Providing the data of approved JAK inhibitors in the management of Rheumatoid Arthritis and IL 17 in the management of Psoriatic Arthritis.
- Sharing clinical cases of RA and PsA.
- Safety and efficacy profile of JAK Inhibitor & IL17.

About Organizer

• Virtual Medical Academy

Additional items to the activity

Optional Details	Type	Fee
JAK Inhibitor & IL17: Improving Outcomes and Exceeding Expectations Certificate	Certificate	Free

VAT 15% Included